BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Podvin S, Dang X, Meads M, Kurabi A, Costantini T, Eliceiri BP, Baird A, Coimbra R. Esophageal cancer-related gene-4 (ECRG4) interactions with the innate immunity receptor complex. Inflamm Res 2015;64:107-18. [PMID: 25511108 DOI: 10.1007/s00011-014-0789-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Li C, Zhang P, Jiang A, Mao JH, Wei G. A short synthetic peptide fragment of human C2ORF40 has therapeutic potential in breast cancer. Oncotarget 2017;8:41963-74. [PMID: 28410214 DOI: 10.18632/oncotarget.16713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Macron C, Lane L, Núñez Galindo A, Dayon L. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification. J Proteome Res 2018;17:4113-26. [PMID: 30124047 DOI: 10.1021/acs.jproteome.8b00300] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
3 Qin X, Zhang P. ECRG4: a new potential target in precision medicine. Front Med 2019;13:540-6. [PMID: 30003403 DOI: 10.1007/s11684-018-0637-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Dorschner RA, Lee J, Cohen O, Costantini T, Baird A, Eliceiri BP. ECRG4 regulates neutrophil recruitment and CD44 expression during the inflammatory response to injury. Sci Adv 2020;6:eaay0518. [PMID: 32195341 DOI: 10.1126/sciadv.aay0518] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 You Y, Li H, Qin X, Ran Y, Wang F. Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis--A short Report. Cell Oncol (Dordr) 2016;39:89-95. [PMID: 26631111 DOI: 10.1007/s13402-015-0260-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
6 Costantini TW, Coimbra R, Lopez NE, Lee JG, Potenza B, Smith A, Baird A, Eliceiri BP. Monitoring Neutrophil-Expressed Cell Surface Esophageal Cancer Related Gene-4 after Severe Burn Injury. Surg Infect (Larchmt) 2015;16:669-74. [PMID: 26460850 DOI: 10.1089/sur.2014.209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
7 Porzionato A, Rucinski M, Macchi V, Sarasin G, Malendowicz LK, De Caro R. ECRG4 expression in normal rat tissues: expression study and literature review. Eur J Histochem 2015;59:2458. [PMID: 26150152 DOI: 10.4081/ejh.2015.2458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
8 Moriguchi T, Takeda S, Iwashita S, Enomoto K, Sawamura T, Koshimizu U, Kondo T. Ecrg4 peptide is the ligand of multiple scavenger receptors. Sci Rep 2018;8:4048. [PMID: 29511297 DOI: 10.1038/s41598-018-22440-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
9 Deng P, Chang XJ, Gao ZM, Xu XY, Sun AQ, Li K, Dai DQ. Downregulation and DNA methylation of ECRG4 in gastric cancer. Onco Targets Ther 2018;11:4019-28. [PMID: 30034241 DOI: 10.2147/OTT.S161200] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
10 Kyd JM, Hotomi M, Kono M, Kurabi A, Pichichero M, Ryan A, Swords WE, Thornton R. Panel 5: Immunology. Otolaryngol Head Neck Surg 2017;156:S63-75. [DOI: 10.1177/0194599816663886] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Dang X, Coimbra R, Mao L, Podvin S, Li X, Yu H, Costantini TW, Zeng X, Larocca D, Eliceiri BP, Baird A. Open reading frame mining identifies a TLR4 binding domain in the primary sequence of ECRG4. Cell Mol Life Sci 2019;76:5027-39. [PMID: 31190084 DOI: 10.1007/s00018-019-03159-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Sallee NA, Lee E, Leffert A, Ramirez S, Brace AD, Halenbeck R, Kavanaugh WM, Sullivan KMC. A Pilot Screen of a Novel Peptide Hormone Library Identified Candidate GPR83 Ligands. SLAS Discov 2020;25:1047-63. [PMID: 32713278 DOI: 10.1177/2472555220934807] [Reference Citation Analysis]
13 Kondo T. Glioblastoma-initiating cell heterogeneity generated by the cell-of-origin, genetic/epigenetic mutation and microenvironment. Semin Cancer Biol 2021:S1044-579X(20)30262-5. [PMID: 33453403 DOI: 10.1016/j.semcancer.2020.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Li L, Li X, Wang W, Gao T, Zhou Y, Lu S. Soluble purified recombinant C2ORF40 protein inhibits tumor cell growth in vivo by decreasing telomerase activity in esophageal squamous cell carcinoma. Oncol Lett 2016;12:2820-4. [PMID: 27698864 DOI: 10.3892/ol.2016.4935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]